Medicare Enrolled

Dr. Marcy Canary, M.D.

Hematology & Oncology · Cooperstown, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1 ATWELL RD, Cooperstown, NY 13326
6075476736
Registered in NPPES since 2006
NPI: 1053400739 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Canary from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Canary? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Canary

Dr. Marcy Canary is a hematology & oncology specialist in Cooperstown, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Canary performed 643 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Canary received a total of $8,555 from 58 pharmaceutical and/or device companies across 483 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Canary is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ 643 Medicare services $8,555 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
643
Medicare services
Bottom 45% in NY for hematology & oncology
Not available
Unique patients (not deduplicated)
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
544 $69 $200
Telephone or electronic consultation, at least 5 minutes
A remote assessment and management service provided by a consulting physician via telephone, internet, or electronic health record. The service requires at least 5 minutes of time and includes a written report.
25 $26 $72
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
24 $61 $122
New patient office visit, complex (60-74 min) 20 $124 $342
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
19 $134 $337
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
11 $101 $277
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,555
Total received (2018-2024)
Avg $1,222/year across 7 years
Top 27% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
483
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,020
2023
$2,088
2022
$1,891
2021
$681
2020
$354
2019
$909
2018
$612

Payments by company (2024)

Takeda Pharmaceuticals U.S.A., Inc.
$248
Daiichi Sankyo Inc.
$240
Celgene Corporation
$148
E.R. Squibb & Sons, L.L.C.
$146
Novartis Pharmaceuticals Corporation
$125
Eisai Inc.
$123
AstraZeneca Pharmaceuticals LP
$122
Merck Sharp & Dohme LLC
$111
PFIZER INC.
$105
Janssen Biotech, Inc.
$95
Regeneron Healthcare Solutions, Inc.
$87
Astellas Pharma US Inc
$76
Lilly USA, LLC
$73
ABBVIE INC.
$43
Genentech USA, Inc.
$34
Sumitomo Pharma America, Inc.
$26
SERVIER PHARMACEUTICALS LLC
$23
SOBI, INC
$22
EMD Serono, Inc.
$22
Blueprint Medicines Corporation
$21
ImmunoGen, Inc.
$21
GENZYME CORPORATION
$21
Ipsen Biopharmaceuticals, Inc
$19
Karyopharm Therapeutics Inc.
$19
PUMA BIOTECHNOLOGY, INC.
$17
Gilead Sciences, Inc.
$17
TerSera Therapeutics LLC
$16
Top 3 companies account for 31.5% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$870
AstraZeneca Pharmaceuticals LP
$630
Daiichi Sankyo Inc.
$604
PFIZER INC.
$569
Novartis Pharmaceuticals Corporation
$455
Celgene Corporation
$421
Regeneron Healthcare Solutions, Inc.
$413
Janssen Biotech, Inc.
$378
Amgen Inc.
$360
Merck Sharp & Dohme LLC
$310
Merck Sharp & Dohme Corporation
$280
Lilly USA, LLC
$268
Takeda Pharmaceuticals U.S.A., Inc.
$265
EMD Serono, Inc.
$214
Eisai Inc.
$202
Pharmacyclics LLC, An AbbVie Company
$183
Incyte Corporation
$183
Astellas Pharma US Inc
$181
Exelixis Inc.
$165
Genentech USA, Inc.
$146
GENZYME CORPORATION
$134
BeiGene USA, Inc.
$103
Bayer HealthCare Pharmaceuticals Inc.
$81
TerSera Therapeutics LLC
$74
SERVIER PHARMACEUTICALS LLC
$68
Gilead Sciences, Inc.
$68
Karyopharm Therapeutics Inc.
$67
Boehringer Ingelheim Pharmaceuticals, Inc.
$66
Seagen Inc.
$66
Adaptive Biotechnologies Corporation
$48
Pharmacosmos Therapeutics Inc.
$47
ABBVIE INC.
$43
Seattle Genetics, Inc.
$39
GlaxoSmithKline, LLC.
$36
ImmunoGen, Inc.
$36
Puma Biotechnology, Inc.
$35
Foundation Medicine, Inc.
$34
Myriad Genetic Laboratories, Inc.
$33
Taiho Oncology, Inc.
$28
Sumitomo Pharma America, Inc.
$26
CTI BioPharma Corp.
$25
EISAI INC.
$23
SOBI, INC
$22
Mirati Therapeutics, Inc.
$22
Blueprint Medicines Corporation
$21
Ipsen Biopharmaceuticals, Inc
$19
Alexion Pharmaceuticals, Inc.
$19
TAIHO ONCOLOGY, INC.
$18
Verastem, Inc.
$18
PUMA BIOTECHNOLOGY, INC.
$17
TG Therapeutics, Inc.
$17
Rigel Pharmaceuticals, Inc.
$16
MorphoSys, US Inc.
$16
Pharmacyclics LLC, an AbbVie Company
$15
Clovis Oncology, Inc.
$15
Apellis Pharmaceuticals, Inc.
$14
ADC Therapeutics America, Inc.
$14
Servier Pharmaceuticals LLC
$13
Top 3 companies account for 24.6% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AUGTYRO · Abraxane · Alecensa · Avastin · BAVENCIO · BLENREP · BOSULIF · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · ELAHERE · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · Elahere · Empaveli · Enhertu · FASLODEX · FRUZAQLA · Fabhalta · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nplate · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PROMACTA · Padcev · Perjeta · Pomalyst · REBLOZYL · RYBREVANT · RYDAPT · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · Stivarga · TECVAYLI · TIBSOVO · TRAZIMERA · TUKYSA · Tavalisse · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · VERZENIO · VONJO · Vanflyta · Vonjo · Vyloy · XALKORI · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Cooperstown?
Compare hematology & oncology specialists in the Cooperstown area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
5
County median income
$67,086
Nearest hospital to ZIP centroid (approximate)
BASSETT HEALTHCARE
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Canary is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Canary experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Canary performed 544 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Canary receive payments from pharmaceutical companies?
Yes. Dr. Canary received a total of $8,555 from 58 companies across 483 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Canary's costs compare to other hematology & oncology specialists in Cooperstown?
Dr. Canary's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Canary) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →